TFFP
Tff Pharmaceuticals Inc (TFFP)
$5.97
Key Stats
$5.935
Day's Range
$6.43
$3.6
52-Week Range
$9.96
| Returns | |
| 1 month return | 5.6% |
| 3 month return | 26.68% |
| 1 year return | 29.8% |
| 5 year return | 18.93% |
Company Information
TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms that the TFF platform can significantly improve the solubility and absorption of poorly water-soluble drugs, a class of drugs that comprises approximately one-third of the major pharmaceuticals worldwide, thereby improving their pharmacokinetics. TFF Pharmaceuticals has two lead drug candidates: Voriconazole Inhalation Powder and Tacrolimus Inhalation Powder. The Company plans to add to this pipeline by collaborating with large pharmaceutical partners. The TFF Platform is protected by 42 patents issued or pending in the US and internationally.
| Organization | Tff Pharmaceuticals Inc |
| Employees | 4 |
| CEO | |
| Industry | Health Technology |
Analyst Recommendation
based on 10 analysts ratings
Buy
90%
Buy
10%
Hold
0%
Sell
Based on 10 Wall street analysts offering stock ratings for Tff Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)
Recommendation Trend
Based on 10 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 9 | 9 | 8 |
| Hold | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Highlights
| Market Capitalization | 127.1M |
| Book Value | 1.53 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0 |
| Earnings Share | -1.25 |
| Wall Street Target Price | 19.67 |
Valuation
| Trailing PE | 0.0 |
| Forward PE | 0.0 |
| Price/Sales (ttm) | 1441.82 |
| Price/Book (mrq) | 3.57 |
| Enterprise Value | 104.5M |
| Enterprise Value/Revenue | 0.0 |
| Enterprise Value/Ebitda | 0.0 |
Technicals
| Beta | 2.13 |
| 50 Day MA | 6.29 |
| 200 Day MA | 7.36 |
Institutional Holdings
DRW Securities, LLC
3.94%
Vanguard Group Inc
3.41%
Carlson Capital LP
1.22%
BlackRock Inc
1.01%
Gagnon Securities LLC
1.0%
Geode Capital Management, LLC
0.73%
